CIPO trademark

OJJAARA

RegisteredCIPOWord markClass 5

"OJJAARA" is a word mark owned by GlaxoSmithKline LLC, filed at the CIPO on June 3, 2022. It is registered and covers class 5 (Pharmaceuticals).

View GlaxoSmithKline LLC portfolioGet this data via the API
Official CIPO record
OJJAARA
Word mark as filed with the CIPO
Status
Registered
Since August 15, 2025
Filed
June 3, 2022
Registered
August 15, 2025
Expires
August 15, 2035
Application no.
2189752
Registration no.
TMA1339569
Office
CIPO
Canadian Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns OJJAARA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

GlaxoSmithKline LLC

United States

857 trademarks in the portfolioView company

Representative

Borden Ladner Gervais LLP

Borden Ladner Gervais LLP

Goods and services

What the mark covers

The products and services OJJAARA is filed for, grouped by Nice class.

  • Pharmaceutical preparations and drugs for the treatment of cancer, namely, Myelofibrosis (MF); pharmaceutical preparations and drugs for the treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases or disorders; Biological preparations made from living tissues and human blood cells for the treatment of cancer; Pharmaceutical products, preparations, and compounds for the prevention and treatment of cancer and tumors, treatment of blood diseases or disorders, bone and bone marrow diseases, and cancers associated with blood diseases or disorders; Pharmaceutical preparations and substance for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Medical diagnostic reagents, assays, and test kits for testing of body fluids; DNA damage response assets, namely, pharmaceutical preparations for the treatment of conditions associated with DNA damage, namely cancer, for medical use.

History

What has happened so far

Steps recorded by the CIPO, newest first.

  1. Registered
  2. Registration Pending
  3. Advertised; Vol.72 Issue 3683
  4. Approval Notice Sent; APPROVED BY PROGRAM EX200M1
  5. Approved; APPROVED BY PROGRAM EX200M1
  6. Agent Changed; From/De: 5153 To/A: 4
  7. Examiner's First Report
  8. Search Recorded
  9. Search Recorded
  10. Search Removed

10 earlier steps on the official record.

FAQ

About OJJAARA

Who owns the trademark "OJJAARA"?

The CIPO trademark "OJJAARA" (application 2189752) is owned by GlaxoSmithKline LLC.

What is the status of "OJJAARA"?

Its status at the CIPO is: registered.

When was "OJJAARA" registered?

It was registered on August 15, 2025 and is due to expire on August 15, 2035.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull OJJAARA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_019deb1e-7412-758a-9317-2b89894675ee
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019deb1e-7412-758a-9317-2b89894675ee",
  "object": "trademark",
  "mark_text": "OJJAARA",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "CA",
  "application_number": "2189752",
  "filing_date": "2022-06-03",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "GlaxoSmithKline LLC",
      "entity_id": "ent_019ebbad-4be6-7544-bafb-06b4c2a2ecb2"
    }
  ]
}